Torreya Partners
Torreya Partners is a boutique investment banking firm founded in 2007 in New York that specializes in advisory services for healthcare clients, spanning pharmaceuticals, pharma licensing, diagnostics, life-science tools, and medical technology across the USA, UK, Canada, and France.
- Company typePrivate
- Founded2007
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Torreya Partners does
Torreya Partners is a boutique investment banking firm founded in 2007 and headquartered in New York, United States. The firm focuses exclusively on the healthcare sector, with service lines spanning pharmaceuticals, pharma licensing transactions, diagnostics, life-science tools, and medical technology. It positions itself as a specialist advisor supporting M&A, capital-raising, and licensing mandates for healthcare companies and their investors across development stages.
The firm operates as a private company with 11–50 employees and claims service coverage across the USA, United Kingdom, Canada, and France, enabling cross-border transaction support for pharmaceutical and medtech clients. Its competitive posture is built on sector specialization rather than breadth, which is the typical model for boutique healthcare advisory firms that compete on domain expertise and senior-level attention rather than balance-sheet products. Co-founder Mark Simon is listed as a co-founder and advisor, reflecting an ongoing senior role.
The business model follows the standard investment banking advisory construct: advisory fees and success-based transaction fees on M&A, licensing, and capital-raising engagements. No disclosed pricing, transaction league-table credits, or financials are available in the input data, so revenue scale and recent activity levels cannot be verified. The firm does not disclose proprietary technology, AI/ML capabilities, or productized tools; its primary deliverable is bespoke advisory service delivered by senior bankers.
Torreya Partners firmographics
Firmographics- Name
- Torreya Partners
- Legal name
- Torreya Partners
- Website
- https://torreya.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Torreya Partners is a boutique investment banking firm founded in 2007 in New York that specializes in advisory services for healthcare clients, spanning pharmaceuticals, pharma licensing, diagnostics, life-science tools, and medical technology across the USA, UK, Canada, and France.
- Ownership category
- akta.pro rank
Torreya Partners industry classification
Industry- Product category
- Healthcare Investment Banking
- NAICS
- Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF)
- akta.pro secondary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Torreya Partners is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Torreya Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Torreya Partners product offering
Product offeringCore offering
Torreya Partners is a boutique investment banking firm that provides advisory and capital-raising services focused on the healthcare and life sciences sectors, including pharmaceuticals, pharma licensing, diagnostics, life science tools, and medical technology. The firm supports clients with M&A advisory, equity and debt capital markets transactions, licensing transactions, and strategic advisory across the healthcare ecosystem.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharma and Biotech Investment Banking Advisory
- Pharma Licensing Advisory
- Diagnostics and Life Science Tools Advisory
- Medical Technology (Medtech) Advisory
Companies that use Torreya Partners
Customer profileIdeal customer profiles1 record
Torreya Partners technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Torreya Partners partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
Torreya Partners competitors and assessment
Company assessmentDirect peers
- Piper Sandler (Healthcare Group): Middle-market healthcare investment bank with deep biopharma, medtech, and diagnostics coverage; competes with Torreya on similar mid-cap follow-on offerings and M&A mandates.
- Leerink Partners: Healthcare-dedicated investment bank (now part of the broader Lazard franchise) with deep focus on biopharma, medtech, and diagnostics — directly competes with Torreya for mid- and large-cap healthcare mandates.
- Stifel Institutional (Healthcare Investment Banking Group): Operating a 47-person global healthcare team with $79.1B+ raised across 440+ transactions, Stifel is a directly comparable full-service healthcare investment banking competitor covering biopharma, medtech, diagnostics, and healthtech.
- Oppenheimer & Co. (Healthcare Investment Banking): Middle-market investment bank with a dedicated healthcare group covering biopharma, medtech, and diagnostics — closely comparable boutique-to-middle-market competitor to Torreya.
- Cantor Fitzgerald (Healthcare): Healthcare-focused investment banking franchise serving biopharma, medtech, and diagnostics issuers — closely comparable in size and mid-market focus to Torreya.
- Cowen (TD Cowen Healthcare Investment Banking): Healthcare-dedicated advisory and capital markets franchise (now part of TD Securities) with strong biopharma, diagnostics, and tools coverage — directly comparable to Torreya's positioning.
- Guggenheim Securities (Healthcare): Bulge-adjacent healthcare investment banking group covering biopharma, life sciences tools, and medtech, frequently co-bookrunning large follow-on and IPO mandates in the same deal pool as Torreya.
Broad incumbents
- Lazard (Healthcare Investment Banking): Premium global advisory firm with a sizable healthcare practice following its acquisition of Leerink — competes with Torreya for selective high-value healthcare M&A mandates.
- Jefferies (Global Healthcare Investment Banking): Large diversified investment bank with a dedicated global healthcare group covering biopharma, diagnostics, and medtech — relevant competitor for capital markets and M&A mandates in Torreya's coverage areas.
- RBC Capital Markets (Healthcare Investment Banking): Bulge-bracket bank with a sizable healthcare investment banking practice covering biopharma, pharma services, and life sciences tools — competes for larger healthcare mandates.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Torreya Partners social profiles
Digital presenceTorreya Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Torreya Partners leadership team
Management profileNumber of profiles
Profiles1 record
Torreya Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Torreya Partners M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Torreya Partners
What does Torreya Partners do?
Torreya Partners is a boutique investment banking firm that provides advisory and capital-raising services focused on the healthcare and life sciences sectors, including pharmaceuticals, pharma licensing, diagnostics, life science tools, and medical technology. The firm supports clients with M&A advisory, equity and debt capital markets transactions, licensing transactions, and strategic advisory across the healthcare ecosystem.
Is Torreya Partners a public or private company?
Torreya Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Torreya Partners founded?
Torreya Partners was founded in 2007. It employs 11 to 50 people.
Where is Torreya Partners based?
Torreya Partners is headquartered in New York, United States, in the North America region.
Who are Torreya Partners's main competitors?
Direct peers on record are Piper Sandler (Healthcare Group), Leerink Partners, Stifel Institutional (Healthcare Investment Banking Group), Oppenheimer & Co. (Healthcare Investment Banking), Cantor Fitzgerald (Healthcare), Cowen (TD Cowen Healthcare Investment Banking) and Guggenheim Securities (Healthcare). Broad incumbents are Lazard (Healthcare Investment Banking), Jefferies (Global Healthcare Investment Banking) and RBC Capital Markets (Healthcare Investment Banking).
Does Torreya Partners have an API?
No public API is recorded for Torreya Partners.
What industry is Torreya Partners in?
Torreya Partners's product category is Healthcare Investment Banking. Its primary akta.pro industry code is FSANAHAF, Corporate Strategic Partnership & Ecosystem Investment Arms, with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523 and its SIC code is 6211.